- Home
- NNOX vs TNYA Comparison
NNOX vs TNYA Comparison
Compare NNOX & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NNOX | TNYA |
|---|---|---|
| Founded | 2011 | 2016 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Medical Electronics | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.6M | 178.5M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NNOX | TNYA |
|---|---|---|
| Price | $2.21 | $0.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $7.00 | $5.33 |
| AVG Volume (30 Days) | 593.1K | ★ 5.0M |
| Earning Date | 03-31-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 54.96 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $20.19 | N/A |
| Revenue Next Year | $137.69 | $1,456.12 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.11 | $0.36 |
| 52 Week High | $5.72 | $2.35 |
Technical Indicators
Market Signals| Indicator | NNOX | TNYA |
|---|---|---|
| Relative Strength Index (RSI) | 32.56 | 40.06 |
| Support Level | $2.11 | $0.66 |
| Resistance Level | $2.75 | $0.70 |
| Average True Range (ATR) | 0.12 | 0.07 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 6.36 | 1.70 |
Price Performance
Historical ComparisonAbout NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.